Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28018587 | 0.98 | CYP3A4 (0.38) | CYP3A4TDP1LTA4HTP53ESR1 | |
| SCHEMBL11209353 | 0.93 | CYP3A4 (0.35) | CYP3A4TDP1LTA4HTP53ESR1 | |
| SCHEMBL10792824 | 0.89 | CYP3A4 (0.35) | CYP3A4TDP1LTA4HTP53ESR1 | |
| SCHEMBL11209432 | 0.86 | LTA4H (0.43) | CYP3A4TDP1LTA4HTP53NPSR1 | |
| SCHEMBL8939051 | 0.85 | LTA4H (0.39) | CYP3A4TDP1LTA4HRELATSHR | |
| SCHEMBL27823965 | 0.82 | PDK2 (0.35) | CYP3A4TDP1LTA4HTP53RELA | |
| SCHEMBL4457781 | 0.81 | LMNA (0.39) | CYP3A4TDP1LTA4HTP53ALDH1A1 | |
| Pyridine SCHEMBL11205969 | 0.80 | KDM4E (0.33) | CYP3A4TDP1MEN1KMT2A | |
| SCHEMBL8939035 | 0.80 | SCN4A (0.37) | CYP3A4NPSR1TSHRL3MBTL1KCNH2 | |
| SCHEMBL196443 | 0.80 | CYP3A4 (0.39) | CYP3A4TDP1LTA4HTP53ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 699 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4666334-A2 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| WO-2025214993-A1 | IONIC CONDUCTIVE MEMBRANES | SPECIALTY OPERATIONS FRANCE (FR) | 2025-10-16 | — | — | WO | claimed |
| WO-2025214992-A1 | IONIC CONDUCTIVE MEMBRANES | SPECIALTY OPERATIONS FRANCE (FR) | 2025-10-16 | — | — | WO | claimed |
| US-20250273736-A1 | FLEXIBLE BATTERY | Anthro Energy, Inc. (US) | 2025-08-28 | — | — | US | claimed |
| CN-115894556-B | Synthesis method of beta-fluoroallylphosphine | 南通大学 | 2025-04-29 | — | — | CN | claimed |
| US-12258506-B2 | Films comprising bright silver based quaternary nanostructures | SHOEI CHEMICAL INC. (JP) | 2025-03-25 | — | — | US | claimed |
| US-12191447-B2 | Gel electrolyte composition for a battery and a method of implementation | Anthro Energy, Inc. (US) | 2025-01-07 | — | — | US | claimed |
| US-20240300993-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-09-12 | — | — | US | claimed |
| WO-2024173770-A2 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2024-08-22 | — | — | WO | claimed |
| US-20240283017-A1 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2024-08-22 | — | — | US | claimed |
| US-6841651-B2 | Polyamide resin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-01-11 | — | — | US | claimed |
| US-20030199667-A1 | Polyamide resin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2003-10-23 | — | — | US | claimed |
| EP-1354906-A1 | Polyamide resin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2003-10-22 | — | — | EP | claimed |
| EP-0010565-B1 | PROCESS FOR PREPARING N-TRITYLIMIDAZOLE COMPOUNDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-11-10 | — | — | EP | claimed |
| EP-0001149-B1 | PROCESS FOR THE PREPARATION OF 3-BROMOMETHYL-3-CEPHEM-SULPHOXIDE DERIVATIVES | GIST-BROCADES N.V. (NL) | 1981-06-03 | — | — | EP | claimed |
| US-4216333-A | Process for preparing N-tritylimidazole compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-08-05 | — | — | US | claimed |
| EP-0010565-A1 | Process for preparing N-tritylimidazole compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-05-14 | — | — | EP | claimed |
| US-4182870-A | BROMINATION, DEBROMINATION | GIST-BROCADES N.V. (NL) | 1980-01-08 | — | — | US | claimed |
| EP-0001149-A1 | Process for the preparation of 3-bromomethyl-3-cephem-sulphoxide derivatives | GIST-BROCADES N.V. (NL) | 1979-03-21 | — | — | EP | claimed |
| US-4126632-A | OF ACRYLONITRILE TO 1,4-DICYANOBUTENES | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-11-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240300993-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | NSUN3, NSUN2, NOP2 | CYP3A4 4088/4885TDP1 166/4885LTA4H 3351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.